MEDPACE HOLDINGS INC (MEDP)
US58506Q1094 - Common Stock
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
MEDP Stock Earnings: Medpace Hldgs Beats EPS, Misses Revenue for Q1 2024
MEDP stock results show that Medpace Hldgs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
MEDP Stock Earnings: Medpace Hldgs Beats EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Medpace Hldgs (NASDAQ:MEDP) just reported results for the first quarter of 2024...
Medpace Holdings, Inc. Reports First Quarter 2024 Results
Noteworthy Monday Option Activity: MEDP, DUK, FUBO
Uber Leads Five Stocks Near Buy Points
Five resilient stocks are setting up or flirting with entries.
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.
Agilent Technologies Stock Getting Closer To Key Technical Benchmark
Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71.
Contract research firms gain after Q4 results (NYSE:IQV)
Shares of contract research organizations IQVIA Holdings (IQV) and Charles River Laboratories (CRL) gain as their Q4 results exceed expectations. Read more here.
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Results
Notable Friday Option Activity: HRL, RXO, MEDP
Commit To Purchase Medpace Holdings At $280, Earn 63.3% Annualized Using Options
Notable Thursday Option Activity: ADBE, MSTR, MEDP
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 12, 2024
Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
The overall sector may be struggling after COVID, but there's still great potential in these three biotech stocks.
Medpace Holdings 10% owner sells over 46K shares (NASDAQ:MEDP)
Medpace Holdings 10% owner sells $12.88M worth of shares. 26 insider trades in the last 3 months.
Medpace Holdings 10% owner discloses sale of 25K shares (NASDAQ:MEDP)
Medpace Holdings reports 10% owner's sale of 25,000 shares worth $6.93M.
3 Top Growth Stocks to Carry You Through 2023
Interest rate headwinds have abated, providing a catalyst for these growth stocks to buy to rally into year-end.
Stock Buybacks: The Good and the Bad
We've also got a look at takeaways from a trip to Las Vegas and some financial horror stories.